Disinfection byproducts (DBPs) in water distribution systems (WDS) are monitored for regulatory compliance, while populations are exposed to DBPs in tap water that may be different due to stagnation of water in plumbing pipes (PP) and heating in hot water tanks (HWT). This study investigated the effects of water stagnation in PP and HWT on exposure and risk of DBPs to humans.
INTRODUCTION
Disinfection byproducts (DBPs) in municipal water have been a concern due to their possible association with cancer and non-cancer risks to humans (USEPA , ; In most of these studies (Nuckols et However, changes in DBPs due to stagnation of water in PP and/or heating in HWT were not explained in this study.
Human exposure assessments are associated with uncer- 
Exposure assessment

Ingestion pathway
Cancer risk through ingestion of DBPs with drinking water is typically predicted following USEPA (). The chronic daily intake (CDI) of DBPs through the ingestion route is predicted as:
where CDI ing ¼ CDI via ingestion (mg/kg-day); Cw ¼ concentration of THMs in drinking water (μg/L); IR ¼ drinking water ingestion rate (L/day); EF ¼ exposure frequency (days/year); ED ¼ exposure duration (year); BW ¼ body weight (kg); AT ¼ averaging time (days); and CF ¼ mass conversion factor from μg to mg (0.001). Details of the parameters for predicting risks are shown in Table 1 .
Inhalation pathway
HAAs are non-volatile and thus are unlikely to impose risk through the inhalation pathway. The CDI of THMs through the inhalation pathway can be estimated following USEPA () as:
where CDI inh ¼ CDI of THMs through inhalation (mg/kgday); E r ¼ absorption efficiency through respiratory system; C a ¼ THMs in shower air (μg/m 3 ); R ¼ breathing rate (m 3 / min); t ¼ shower duration (min/shower); F ¼ shower frequency (shower/day); EF ¼ exposure frequency (days/year);
ED ¼ exposure duration (year); BW ¼ body weight (kg);
AT ¼ averaging time (days); and CF ¼ mass conversion factor from μg to mg (0.001). C a depends on several factors, including THMs in shower water, shower stall volume, water flow rate, partition coefficient of THMs from water to air and air exchange rate of shower stall. Chowdhury () predicted C a using the following approach:
Assuming that the background concentration of THMs is zero prior to the showering event, the boundary condition can be introduced as: C a j t¼0 ¼ 0. Such that the solution of Equation (3) becomes:
where Q w ¼ water flow (L/min); V ¼ shower stall volume (m 3 ); C w ¼ THMs in cold water (μg/L); k a ¼ shower air exchange rate (min À1 ); P v ¼ transfer efficiency of THMs from water to air. In Equation (4) (McKone 1987; USEPA 1998 USEPA , 2011 Xu et al. 2002; Xu & Weisel 2003 , 2005 Chowdhury () used the following equation to predict THMs growth rate and THMs in the shower water:
where T ¼ temperature of water ( W C); and k ¼ THMs growth rate at T W C (min À1 ). Using Equation (5), THMs in the heated water during showering can be estimated as:
where C hw ¼ THMs in heated water (μg/L); C w ¼ THMs in cold water (μg/L); k 1 ¼ THMs formation rate for heated water (min À1 ), which can be estimated using Equation (5); k 2 ¼ THMs formation rate for cold water (min À1 ); and t ¼ shower duration (min). Using C hw instead of C w in Equation (4), shower air concentration (C a ) is estimated. THMs in the air within the shower stall (C a ) are used in Equation (2) to predict CDI inh . As demonstrated, THMs formation rates (Equations (5) and (6)) are subject to the presence of residual organics and FRC, while both can be available in shower water. As such, an increased temperature during showering may form additional THMs in shower water.
Dermal contact pathway
The molecular weight (MW) and octanol-water partition coefficient (K ow ) of THMs are in the ranges of 119.4-252.8 g/mole and 93-128 g/mole, respectively. The MW and K ow of HAAs are 94.5-296.7 g/mole and 1.7-21.4 g/mole, respectively. The technical report on the assessment of nonoccupational exposure to nonionizing chemicals noted that chemicals with K ow between 0.1 and 10 5 and MW less than 700 g/mole might be absorbed through human skin (ECETOC ). It is plausible that THMs and HAAs may be absorbed through human skin during showering and/or swimming (ECETOC ), which may pose a risk to human health.
The CDI through the dermal route needs to be assessed by incorporating the unsteady and steady states of exposures. For DBPs, lag times to achieve steady state between the water attached to skin and the stratum corneum of skin are different, which can be in the range of 7.5-218.3 minutes (Chowdhury ). In many cases, showering duration can be less than the lag times. As such, unsteady state analysis is necessary for exposure assessment in these cases (Chowdhury ) . The unsteady state and steady state estimates of DBPs exposure through the dermal route can be different (Chowdhury ) . The steady state diffusion of low and high MW compounds through the stratum corneum was reported to be in the order of 10 À13 -10 À14 m 2 /s and 10 À15 -10 À17 m 2 /s, respect- 
where L t ¼ lag time (h); d skin ¼ thickness of stratum corneum (cm); D skin ¼ molecular diffusion of chemical through stratum corneum (cm 2 /h). The molecular diffusion (D skin ) is estimated as:
where MW ¼ molecular weight (g/mol); K ow ¼ octanol-water partition coefficient; K m ¼ partition coefficient between stratum corneum and chemical in water. This can be estimated as:
In predicting influx of DBPs through the stratum corneum, Fick's first law of diffusion can be described as:
where d skin ¼ thickness of the stratum corneum; D skin ¼ molecular diffusion of chemical through the stratum corneum; and ΔC ¼ concentration gradient between the upper and lower layers of the stratum corneum. The influx of DBPs is directly related to concentration gradient between the upper and lower layers of the stratum corneum. It is anticipated that concentrations of DBPs in shower water change exponentially with shower duration (Equations (5) and (6)).
By substituting Equation (6) into Equation (10), we have:
It can be reasonably argued that the concentration gradient between DBPs at the upper and lower layers of the stratum corneum may not follow a linear pattern. To obtain a better prediction, duration of dermal exposure prior to achieving steady-state was discretized into oneminute intervals. Changes of DBPs were estimated for each interval. Thus, Equation (11) takes the form of:
where i ¼ 1, 2, 3,……., n; and the time unit is t/n. The CDI of DBPs through dermal contact during showering can be estimated as:
where CDI dermÀust ¼ CDI of DBPs through dermal contact during the unsteady-state condition (mg/kg-day); J ¼ diffusion through human skin (mg/cm 2 /min); S skin ¼ area of body skin exposed to water (m 2 ); t ¼ duration of shower per event (min/event); F ¼ shower frequency (event/day);
EF ¼ exposure frequency (day/year); ED ¼ exposure duration (year); BW ¼ human body weight (kg); AT ¼ averaging time (day); and CF ¼ 10,000 (conversion factor for skin area from m 2 to cm 2 ). If showering duration is more than the lag time, dermal exposure for the steadystate period can be estimated as:
where CDI dermÀss ¼ CDI of THMs through dermal contact (mg/kg-day) during steady-state; C hw ¼ THMs in warm water (μg/L); S skin ¼ area of body skin exposed to water (m 2 ); P d ¼ permeability of THMs through the skin (m/min); t ss ¼ difference between showering duration and lag time (min/event). The CDI of THMs through the dermal pathway can be obtained as:
The route specific lifetime cancer risk and hazard index (HI) can be determined as: and R f D represents the safe dose that can be ingested without any adverse effect (USEPA ). The CDI were predicted by generating 5,000 random values using the parameter values in Table 1 and the DBPs data in Table 2, which were characterized through statistical distributions in Table 3 . For the parameters in Table 1 , triangular distributions were developed with the ranges as the minimum and maximum and the average as the most likely parameter values. The random data have characterized the uncertainties in the estimates.
Adjustment factor
The USEPA demonstrates that early-life exposure has a greater contribution to cancer appearing later in life. The It is important to emphasize that these adjustments are combined with corresponding age-specific estimates of exposure to assess cancer risk. This is a departure from the way cancer risks have historically been based upon the premise that risk is proportional to the daily average of lifetime dose. The USEPA () showed an example of lifetime exposure for a carcinogenic chemical with slope factor of 2.0 per mg/kg-day and lifetime average dose of 0.0001 mg/kg-day. Without considering the ADAF, risk was estimated to be 0.0002. With ADAF, the risk was estimated to be 0.00033, which is 1.63 times the risk without the ADAF. In this study, the estimated cancer risks were multiplied by 1.63 to better protect human health. However, upon availability of precise exposure data for these age groups (e.g. 0-2, 2-16 and 16 þ years), cancer risks can be predicted for each age group and then normalized over the lifetime.
RESULTS
Occurrences of DBPs in WDS, PP and HWT
The averages and standard deviations of THMs and HAAs are presented in Figure 1 . Concentrations of THMs were higher than HAAs in most of the sampling scenarios. For example, THMs and HAAs in S3 (morning hot water)
were 14.6 μg/L and 9.2 μg/L, respectively, while for S2
(cold water in early morning prior to first use), these were 11.1 μg/L and 8.6 μg/L, respectively (Figure 1) . The water quality parameters and averages of THMs and HAAs are shown in Table 2 . Averages of THMs in WDS (S1, S4 and HAAs (μg/L) 6.4 (1.8) 8.6 (2.8) 9.2 (2.2) 6.7 (2.1) 7.9 (2.5) 9.9 (2.7) 6.9 (2.7) S1: samples from WDS after last use of water in the late evening; S2: cold water samples in the early morning prior to the first water use; S3: hot water samples in the morning; S4: samples from the WDS in the morning; S5: cold water samples in the afternoon, before water use; S6: hot water samples in the afternoon; S7: samples from the WDS in the afternoon; values in brackets represent standard deviations. S7), PP (S2, S5) and HWT (S3, S6) were 6.4-6.94 μg/L, 10.4-11.1 μg/L and 13.2-14.6 μg/L, respectively, while averages of HAAs in WDS, PP and HWT were 6.4-6.9 μg/L, 7.9-8.6 μg/L and 9.2-9.9 μg/L, respectively (Table 2) .
THMs in PP were 20-120% higher than the THMs in WDS. THMs in HWT were 80-260% higher than the THMs in WDS and 20-60% higher than the THMs in PP. versus afternoon) was insignificant. THMs and HAAs in S1, S4 and S7 were statistically comparable (THMs: P > 0.65; HAAs: P > 0.46). For example, THMs in WDS were 6.9 μg/L, 6.5 μg/L and 6.4 μg/L in S1, S4 and S7, respectively. In these samples, HAAs were 6.4 μg/L, 6.7 μg/L and 6.9 μg/L, respectively. THMs and HAAs in PP were statistically comparable (THMs: P ¼ 0.45; HAAs: P > 0.57). THMs in the PP were 11.1 μg/L and 10.4 μg/L in S2 and S5, respectively, while HAAs were 8.6 μg/L and 7.9 μg/L, respectively. No significant change in THMs and HAAs from HWT samples were observed (THMs: P ¼ 0.78;
HAAs: P > 0.59). THMs in S3 were 14.6 μg/L, while they were 13.2 μg/L in S6.
THMs and HAAs in WDS, PP and HWT showed seasonal variability (Figure 2) . In January, THMs in S1 were in the range of 2.3-2.8 μg/L, while in August the range was 7.1-7.6 μg/L (Figure 2) . In January and August, THMs in PP were in the ranges of 5.4-5.9 μg/L and 12.7-13.2 μg/L, respectively. In HWT, ranges of THMs were 5.9-6.5 μg/L On average, CDI of CHCl 3 for PP and HWT were 1.8 and 2.3 times, respectively, higher than the CDI for WDS.
The CDI of DCAA and TCAA for PP and HWT were also higher than the CDI for WDS. For DCAA, ratios of CDI for PP to WDS, HWT to WDS, and HWT to PP were 1.5, 2.4 and 1.6, respectively (Table 4 ). For TCAA, ratios of CDI for PP to WDS, HWT to WDS and HWT to PP were 1.2, 0.8 and 0.7, respectively, indicating that the concentrations of TCAA might have been decreased in the HWT.
Past studies have reported that the increase in water temp- (Table 4) . It is to be noted that CDI of HAAs were through the ingestion and dermal routes and the intake through inhalation was assumed negligible due mainly to their non-volatile nature (Chowdhury et al. ) . Further, coefficients for dermal permeation Figure 3 . Ingestion route was the highest contributor of risks from THMs and HAAs. The risks of HAAs were higher than the risks of THMs through ingestion and dermal routes. For THMs, the ingestion route had the risks Cancer risk WDS THMs 2.12 × 10 À6 7.11 × 10 À7 5.73 × 10 À6 6.18 × 10 À7 HAAs 6.38 × 10 À6 8.64 × 10 À7 3.99 × 10 À5 3.37 × 10 À6 WDS -Total 8.51 × 10 À6 2.28 × 10 À6 4.17 × 10 À5 3.56 × 10 À6 PP THMs 2.68 × 10 À6 7.68 × 10 À7 7.44 × 10 À6 8.23 × 10 À7 HAAs 8.46 × 10 À6 8.11 × 10 À7 3.60 × 10 À5 4.10 × 10 À6 PP -Total 1.11 × 10 À5 2.16 × 10 À6 4.02 × 10 À5 4.37 × 10 À6 HWT THMs 2.82 × 10 À6 1.06 × 10 À6 6.90 × 10 À6 7.81 × 10 À7 HAAs 9.95 × 10 À6 1.73 × 10 À6 3.55 × 10 À5 3.67 × 10 À6 HWT -Total 1.28 × 10 À5 3.34 × 10 À6 3.88 × 10 À5 4.03 × 10 À6 HI WDS THMs 1.86 × 10 À2 4.64 × 10 À3 4.81 × 10 À2 6.69 × 10 À3 HAAs 1.73 × 10 À2 2.07 × 10 À3 1.10 × 10 À1 9.53 × 10 À3 WDS -Total 3.59 × 10 À2 8.02 × 10 À3 1.36 × 10 À1 1.26 × 10 À2 PP THMs 3.24 × 10 À2 7.16 × 10 À3 7.97 × 10 À2 1.09 × 10 À2 HAAs 2.53 × 10 À2 2.23 × 10 À3 1.33 × 10 À1 1.50 × 10 À2 PP -Total 5.77 × 10 À2 1.58 × 10 À2 1.85 × 10 À1 2.01 × 10 À2 HWT THMs 4.13 × 10 À2 6.00 × 10 À3 1.10 × 10 À1 1.49 × 10 À2 HAAs 3.74 × 10 À2 4.97 × 10 À3 1.33 × 10 À1 1.48 × 10 À2 HWT -Total 7.88 × 10 À2 2.12 × 10 À2 2.03 × 10 À1 2.38 × 10 À2 of 1.27 × 10 À6 , 1.6 × 10 À6 and 1.7 × 10 À6 for WDS, PP and HWT, respectively. The risks through the inhalation route were 0.42 × 10 À6 , 0.5 × 10 À6 and 0.6 × 10 À6 , respectively, and HWT are plotted in Figure 5 . In all cases, cancer risks were higher than 1.0 × 10 À6 (Figures 4 and 5) . At risk level 1.0 × 10 À5 , the exceedance probabilities of cancer risks from WDS, PP and HWT are 26.8%, 53.8% and 73.5%, respectively ( Figure 5) . The PP and HWT had 27.0 and 46.7% more chance of exceeding a cancer risk of 1.0 × 10 À5 than the WDS. There is a 4.7%, 16.4% and 25.1%
chance that cancer risks exceed the risk level of 1.5 × 10 À5 in WDS, PP and HWT, respectively. The PP and HWT had 11.7% and 20.4% more chance of exceeding a cancer risk of 1.5 × 10 À5 than the WDS. At a risk level of 2.0 × 10 À5 , the exceedance probabilities are 0.8%, 4.1% and 5.6% in these sources, respectively. At a risk level of 5.0 × 10 À5 , the exceedance probability is zero in all scenarios ( Figure 5 ). In multi-storey residential or office buildings, this can be an issue as water can be stagnant for hours to several days. 
DISCUSSION
